doi:10.19983/j.issn.2096-8493.20253076

[1] 舒薇, 刘宇红. 世界卫生组织《2023年全球结核病报告》解读. 结核与肺部疾病杂志, 2024, 5(1): 15-19. doi:10.19983/j.issn.2096-8493.2024006.
[2] Dominguez J, Boeree MJ, Cambau E, et al.Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 tbnet/resist-tb consensus statement. Lancet Infect Dis, 2023,23(4): e122-37.doi.org/10.1016/S1473-3099(22)00875-1.
[3] Liebenberg D, Gordhan BG, Kana BD.Drug resistant tuberculosis: implications for transmission, diagnosis, and disease management. Front Cell Infect Microbiol, 2022; 12:943545. doi:10.3389/fcimb.2022.943545.
[4] Abad C, Razonable RR.Multi-drug resistant and rifampin-resistant tuberculosis in transplant recipients. Transpl Infect Dis,2023,25(4): e14088. doi.org/10.1111/tid.14088.
[5] Chesov E, Chesov D, Maurer FP, et al.Emergence of bedaquiline resistance in a high tuberculosis burden country. Europ Res J , 2022,59(3):2100621. doi:/10.1183/13993003.00621-2021.
[6] Gygli SM, Borrell S, Trauner A, et al.Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives. FEMS Microbiol Rev,2017,41(3):354-73. doi:10.1093/femsre/fux011.
[7] Wang F, Yuan Z, Qin S, et al.The effects of meteorological factors and air pollutants on the incidence of tuberculosis in people living with HIV/AIDS in subtropical Guangxi, China. BMC Public Health, 2024,24(1):1333. doi:10.1186/s12889-024-18475-0.
[8] Li L, Lv Y, Su L, et al.Epidemiology of extrapulmonary tuberculosis in central Guangxi from 2016 to 2021. Eur J Clin Microbiol Infect Dis,2023,42(2):129-40. doi:10.1007/s10096-022-04524-2.
[9] Lin Y, Liang D, Liang X, et al.Space-time distribution characteristics of tuberculosis and its socioeconomic factors in Southern China from 2015 to 2019. Infect Drug Resist, 2022,15:2603-16. doi:10.2147/IDR.S356292.
[10] Yang DL, Li W, Pan MH, et al.Spatial analysis and influencing factors of pulmonary tuberculosis among students in Nanning, during 2012-2018. PLoS One,2022,17(5): e268472. doi:10.1371/journal.pone.0268472.
[11] Cui Z, Lin D, Chongsuvivatwong V, et al.Spatiotemporal patterns and ecological factors of tuberculosis notification: a spatial panel data analysis in Guangxi, China. PloS One,2019,14(5): e212051. doi:10.1371/journal.pone.0212051.
[12] Pan D, Palittapongarnpim P, Chaiprasert A, et al.Infectivity of Mycobacterium tuberculosis genotypes and outcome of contact investigation in classroom in Guangxi, China. Biomed Res Int,2019, 2019:3980658. doi:10.1155/2019/3980658.
[13] Pan D, Lan R, Graviss EA, et al.Adolescent tuberculosis associated with tuberculosis exposure in classrooms and dorm rooms in Guangxi, China. Int J Infect Dis,2019,78:8-14. doi:10.1016/j.ijid.2018.09.019.
[14] Liang D, Song Z, Liang X, et al.Whole genomic analysis revealed high genetic diversity and drug-resistant characteristics of Mycobacterium tuberculosis in Guangxi, China. Infect Drug Resist, 2023,16:5021-31. doi:10.2147/IDR.S410828.
[15] Lin D, Cui Z, Chongsuvivatwong V, et al.The geno-spatio analysis of Mycobacterium tuberculosis complex in hot and cold spots of Guangxi, China. BMC Infect Dis,2020,20(1):462. doi:10.1186/s12879-020-05189-y.
[16] Lan R, Yang C, Lan L,, et al.Mycobacterium tuberculosis and non-tuberculous mycobacteria isolates from HIV-infected patients in Guangxi, China. The International Journal of Tuberculosis and Lung Disease,2011,15(12):1669-75. doi:10.5588/ijtld.11.0036.
[17] Zhu Y, Wu J, Feng X, et al.Patient characteristics and perceived health status of individuals with HIV and tuberculosis coinfection in Guangxi, China. Medicine (Baltimore), 2017,96(14): e6475. doi:10.1097/MD.0000000000006475
[18] Marston HD, Dixon DM, Knisely JM, et al.Antimicrobial resistance. JAMA, 2016,316(11):1193-204. doi.:10.1001/jama.2016.11764.
[19] Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in2019: a systematic analysis. The Lancet. 2022;399(10325):629-55. https://doi.org/10.1016/S0140-6736(21)02724-0.
[20] Howard NC, Marin ND, Ahmed M, et al.Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes. Nat Microbiol,2018,3(10):1099-108. doi:10.1038/s41564-018-0245-0.
[21] Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, et al.Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. The Lancet. 2018;392(10150):821-34.doi:10.1016/S0140-6736(18)31644-1.
[22] Agarwal S, Sharma A, Bouzeyen R, et al. Vapbc22 toxin-antitoxin system from Mycobacterium tuberculosis is required for pathogenesis and modulation of host immune response. Sci Adv,2020,6(23): eaba6944. doi:10.1126/sciadv.aba6944.
[23] Pillay CS, John N, Barry CJ, et al.Atypical network topologies enhance the reductive capacity of pathogen thiol antioxidant defense networks. Redox Biol,2023,65:102802. doi:org/10.1016/j.redox.2023.102802
[24] Beites T, O'Brien K, Tiwari D, et al. Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development. Nat Commun,2019,10(1):4970. doi.:10.1038/s41467-019-12956-2.
[25] Isakova J, Sovkhozova N, Vinnikov D, et al.Mutations of rpoB, katG, inhA and ahpC genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz republic. BMC Microbiol,2018,18(1):22. doi.:10.1186/s12866-018-1168-x.
[26] Javed H, Bakula Z, Plen M, et al.Evaluation of genotype MTBDRplus and MTBDRsl assays for rapid detection of drug resistance in extensively drug-resistant Mycobacterium tuberculosis isolates in Pakistan. Front Microbiol,2018, 9:2265.doi:10.3389/fmicb.2018.02265.
[27] Al-Mutairi NM, Ahmad S, Mokaddas E, et al.Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis. BMC Infect Dis,2019,19(1):3. doi:10.1186/s12879-018-3638-z.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Nima Qucuo, Lyu Hengliang, Hu Fengmei, Zhang Wenyi, Xu Yuanyong. Spatiotemporal analysis on pulmonary tuberculosis in the Xizang Autonomous Region, 2010—2022 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(3): 304-309.
[2]	Gu Yong, Mo Hui, Chen Hongmei, Lu Bo, Yi Chunmei, Gao Zhidong, Zhou Xiaofeng, Zhang Hongtai. Epidemiological trends of tuberculosis in Yuexi County, Liangshan Yi Autonomous Prefecture, Sichuan Province, 2005—2023 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(3): 310-315.
[3]	Hou Kun, Wu Jinyi, Wang Xiaojun, Peng Peng. Influencing factors and risk prediction of delayed tuberculosis diagnosis in a tertiary hospital in Wuhan, China [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(3): 316-322.
[4]	Cao Hong, Deng Xiaolan, Li Zhen, He Yuqin, Wu Jinju, Lu Lunshan. Analysis of the detection and treatment outcomes of MTB/HIV co-infected patients in Hefei from 2014 to 2023 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(3): 323-329.
[5]	Zhang Leijie, Li Pei, Wang Dan, Li Huiping, Zhu Ni. Influencing factors of diagnostic delay in pulmonary tuberculosis patients: a comparative study using three classification models [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(3): 335-342.
[6]	Wei Yunxia, Wang Xin, Long Xuejuan. Prognostic value of neutrophil-to-lymphocyte ratio combined with serum procalcitonin in patients with severe pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(3): 330-334.
[7]	Chen Hao, Lin Sihan, Li Xiaofen, Liu Zhidong, Lin Yanwei. Analysis of the effectiveness of pulmonary tuberculosis screening for freshmen based on Markov model [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(2): 169-175.
[8]	Wang Ruihua, Bian Huanqing, Ren Yan. Analysis of healthcare-seeking delay and influencing factors for pulmonary tuberculosis among students in Taian City of Shandong Province from 2013 to 2022 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(2): 176-182.
[9]	Ruan Shujin, Chen Jingfang, Wang Xiufen, Zhang Dandan, Li Mengjun, Meng Ting. Analysis of factors influencing treatment non-adherence in pulmonary tuberculosis patients and construction of a risk prediction model [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(2): 183-190.
[10]	Yang Chao, Wang Jing, Tang Guilin, Wang Bin, Liu Hui, Li Xintong. Analysis of diagnosis delay and its influencing factors among elderly pulmonary tuberculosis patients aged 60 and above in Tongzhou District of Beijing, 2016—2022 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(2): 191-197.
[11]	Zhou Qi, Li Mingyi, Wang Jinxiu, Zhang Hongyan, Yang Xuejuan, Mao Lin. Analysis of nutritional status and influencing factors of elderly hospitalized patients with pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(2): 198-203.
[12]	Yu Mingliu, Gong Beibei, Chen Yuehua, Lan Weien, Wei Haiming, Gan Lin, Chen Xianglan. Effectiveness of pulmonary rehabilitation combined with early mobilization program in patients with pulmonary tuberculosis receiving invasive mechanical ventilation [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(2): 217-224.
[13]	Cui Cancan, Li Mingwu. Research progress on Mycobacterium tuberculosis infection in family close contacts of pulmonary tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(2): 234-240.
[14]	. [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(2): 241-244.
[15]	Yan Wenhua, Chen Wenjun. The value of digital health education in the preventive management of caregivers of patients with bacterial positive pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 73-78.